Picture of Axsome Therapeutics logo

AXSM — Axsome Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Brief: Axsome Therapeutics Q3 Net Income USD -64.602 Million

Nov 12 (Reuters) - Axsome Therapeutics Q3 operating expenses USD 167.386
million.
* Q3 pretax profit USD -64.602 million
* Q3 basic EPS USD -1.34
* Q3 operating income USD -62.624 million

Recent news on Axsome Therapeutics

See all news